Injectable Peptides: Out of the Back Alley and Into the Light? Berkley Lifesciences The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and FDA to weigh easing limits on peptides promoted by RFK Jr. NBC 6 South Florida The Peptide Boom Is Getting Out of Hand The Atlantic The Peptide Gamble: A Doctor's Warning on BPC 157 and TB 500